A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications
Kathad, Umesh, Kulkarni, Aditya, McDermott, Joseph Ryan, Wegner, Jordan, Carr, Peter, Biyani, Neha, Modali, Rama, Richard, Jean-Philippe, Sharma, Panna, Bhatia, Kishor
Published in BMC bioinformatics (02.03.2021)
Published in BMC bioinformatics (02.03.2021)
Get full text
Journal Article
The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations
Kulkarni, Aditya, McDermott, Joseph Ryan, Kathad, Umesh, Modali, Rama, Richard, Jean-Philippe, Sharma, Panna, Bhatia, Kishor
Published in Oncotarget (13.04.2021)
Published in Oncotarget (13.04.2021)
Get full text
Journal Article